UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2023
Commission File Number: 001-39591
iHuman Inc.
(Registrant’s Name)
Floor 8, Building B,
No. 1 Wangjing East Road,
Chaoyang District, Beijing 100102
People’s Republic of China
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Form 20-F
x Form 40-F ¨
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
iHuman Inc. |
| |
|
|
|
| |
By |
: |
/s/ Vivien Weiwei Wang |
| |
Name |
: |
Vivien Weiwei Wang |
| |
Title |
: |
Director and Chief Financial Officer |
Date: September 21, 2023
Exhibit 99.1
iHuman
Inc. Announces Second Quarter 2023 Unaudited Financial Results
BEIJING,
China, September 21, 2023 -- iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading provider
of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended
June 30, 2023.
Second Quarter 2023 Highlights
| · | Revenues were RMB241.0 million (US$33.2 million), compared with RMB230.6 million in the same period last
year. |
| · | Gross profit was RMB170.8 million (US$23.6 million), compared with RMB163.2 million in the same period
last year. |
| · | Operating income was RMB40.9 million (US$5.6 million), a year-over-year increase of 80.8%. |
| · | Adjusted operating income1
was RMB43.3 million (US$6.0 million), a year-over-year increase of 75.7%. |
| · | Net income was RMB42.1 million (US$5.8 million), a year-over-year increase of 93.1%. |
| · | Adjusted net income1 was RMB44.5 million (US$6.1 million), a year-over-year increase of 86.8%. |
| · | Average total MAUs2
for the second quarter were 20.33 million, a year-over-year increase of 11.7%. |
Dr. Peng
Dai, Director and Chief Executive Officer of iHuman, commented, “Despite the impact of seasonality on our business, we are pleased
to deliver another quarter of solid results, marked by year-over-year revenue improvement and enhanced profitability. This performance
underscores the resilience of our business model and the effective execution by our team to further solidify our industry-leading position.
During the quarter, we remained committed to our product-driven strategy and to strengthening our portfolio through a combination of cutting-edge
technological innovation and captivating content. Domestically, we further optimized our comprehensive portfolio, rolling out enhancements
to both newer releases and well-established core offerings. For example, within iHuman Little Artists, we launched “Interactive
Art Gallery”, an innovative module designed to introduce children to art and nurture their creativity through an integrated
online-offline experience. Leveraging advanced technologies such as key point recognition, image segmentation and an AI-driven assessment
engine, the module provides children with extensive support throughout their creative journey, including step-by-step instructions, instant
and personalized feedback, and guidance from seasoned art professionals. Within our long-standing flagship app, iHuman Chinese,
which is the prominent market leader in the category, we introduced a new module named “Chinese Characters in Daily Life.”
By integrating Chinese characters into everyday life scenarios and weaving them into intriguing short stories that resonate with children,
the module strengthens children’s familiarity and proficiency with Chinese characters in a fun way. Internationally, we continued
to boost our market presence by diligently enriching our product offerings with enlightening content and innovative features. In particular,
we expanded Aha World with two more highly engaging modules, “My World” and “City.” Designed
to further unleash children’s creativity, these modules offer children a wide array of elements with which they can use their imagination
to custom-design scenes from daily life in the virtual world. The open-ended creative experience offered by these modules received an
enthusiastic reception from our young audience. Looking ahead, we will continue to focus on technological innovation and content excellence
to secure the long-term success of our products and sustainable growth of our business.”
Ms. Vivien
Weiwei Wang, Director and Chief Financial Officer of iHuman, added, “We reported another solid set of results which reflects
our commitment and continued focus on driving sustainable growth and profitability. Our revenues continued to grow year-over-year and
our net income nearly doubled, marking our sixth consecutive quarter of profitability. Our strong and balanced financial position enables
us to continue investing in innovation and cutting-edge technologies to support the sustainable growth of our business. The solid foundation
created by our user base is an integral driver for our long-term growth. During the quarter, our average total MAUs increased by 11.7%
year-over-year to 20.33 million. We are encouraged by the strength and resilience of our diversified business and our ability to execute
on our strategy to drive business growth. As we move into the second half of the year, we will continue to drive business growth and create
value for our shareholders by further enhancing our operational efficiency and strategically investing in long-term growth opportunities,
fortifying our industry-leading position.”
1
“Adjusted operating income” and “adjusted net income” exclude share-based compensation expenses.
Please see “Non-GAAP Financial Measures” and “Unaudited Reconciliation of GAAP and non-GAAP Results” at the end
of this press release.
2
“Average total MAUs” refers to the monthly average of the sum of the MAUs of each of the Company’s apps
during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once
in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.
Second Quarter 2023 Unaudited Financial Results
Revenues
Revenues
were RMB241.0 million (US$33.2 million), an increase of 4.5% from RMB230.6 million in the same period last year, primarily driven
by user expansion and enhanced user engagement.
Average
total MAUs for the quarter were 20.33 million, an increase of 11.7% year-over-year from 18.20 million in the same period last year.
The number of paying users3 was 1.31 million.
Cost of Revenues
Cost
of revenues was RMB70.2 million (US$9.7 million), an increase of 4.1% from RMB67.4 million in the same period last year.
Gross Profit and Gross Margin
Gross
profit was RMB170.8 million (US$23.6 million), an increase of 4.7% from RMB163.2 million in the same period last year. Gross margin
was 70.9%, maintaining approximately the same level from 70.8% in the same period last year.
Operating Expenses
Total operating expenses were RMB130.0 million
(US$17.9 million), a decrease of 7.6% from RMB140.6 million in the same period last year.
Research
and development expenses were RMB63.4 million (US$8.7 million), a decrease of 18.9% from RMB78.2 million in the same period last
year, primarily due to payroll-related cost savings and decreased outsourcing expenses as a result of the continued optimization of our
operational efficiency.
Sales
and marketing expenses were RMB40.6 million (US$5.6 million), an increase of 21.0% from RMB33.5 million in the same period last
year, primarily due to increased strategic spending on promotional activities.
General
and administrative expenses were RMB26.0 million (US$3.6 million), compared with RMB28.8 million in the same period last year.
Operating
Income
Operating
income was RMB40.9 million (US$5.6 million), an increase of 80.8% from RMB22.6 million in the same period last year.
Excluding
share-based compensation expenses, adjusted operating income was RMB43.3 million (US$6.0 million), an increase of 75.7% from RMB24.6
million in the same period last year.
Net Income
Net
income was RMB42.1 million (US$5.8 million), an increase of 93.1% from RMB21.8 million in the same period last year.
3
“Paying users” refers to users who paid subscription fees for premium content on any of the Company’s
apps during a specific period; a user who makes payments across different apps using the same registered account is counted as one paying
user, and a user who makes payments for the same app multiple times in the same period is counted as one paying user.
Adjusted net income was RMB44.5 million (US$6.1
million), an increase of 86.8% from RMB23.8 million in the same period last year.
Basic
and diluted net income per ADS were RMB0.80 (US$0.11) and RMB0.77 (US$0.11), respectively, compared with RMB0.41 and RMB0.40 in
the same period last year. Each ADS represents five Class A ordinary shares of the Company.
Adjusted
diluted net income per ADS was RMB0.81 (US$0.11), compared with RMB0.44 in the same period last year.
Deferred
Revenue and Customer Advances
Deferred revenue and customer advances were RMB325.8
million (US$44.9 million) as of June 30, 2023, compared with RMB379.1 million as of December 31, 2022.
Cash, Cash Equivalents and Time Deposits
Cash,
cash equivalents and time deposits were RMB1,104.8 million (US$152.4 million) as of June 30, 2023, compared with RMB1,050.0
million as of December 31, 2022.
Exchange Rate Information
The U.S. dollar (US$) amounts disclosed in this
press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience
of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical
release of the Board of Governors of the Federal Reserve System as of June 30, 2023, which was RMB7.2513 to US$1.00. The percentages
stated in this press release are calculated based on the RMB amounts.
Non-GAAP Financial Measures
iHuman
considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income
per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation
of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared
and presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).
iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income
and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income
and adjusted diluted net income per ADS enable iHuman’s management to assess its operating results without considering the impact
of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful
information to investors in understanding and evaluating the Company’s current operating performance and prospects in the same manner
as management does, if they so choose.
Non-GAAP financial measures are not defined under
U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which
possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue
to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP
financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore
their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation
from or as a substitute for the financial information prepared and presented in accordance with GAAP.
Safe Harbor Statement
This announcement contains forward-looking statements.
These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act
of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,”
“future,” “intends,” “plans,” “believes,” “estimates” and similar statements.
Statements that are not historical facts, including statements about iHuman’s beliefs and expectations, are forward-looking statements.
Among other things, the description of the management’s quotations in this announcement contains forward-looking statements. iHuman
may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”),
in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors
or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual
results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman’s
growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract
and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the
market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations
regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions
underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman’s filings
with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any
obligation to update any forward-looking statement, except as required under applicable law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered,
intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming
cognitive development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the
parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with
cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman’s unique,
fun and interactive product offerings stimulate children’s natural curiosity and exploration. The Company’s comprehensive
suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety
of areas to develop children’s abilities in speaking, critical thinking, independent reading and creativity, and foster their natural
interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and
big data analysis on children’s behavior & psychology, iHuman believes it will continue to provide superior experience
that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated
suite of tech-powered, intellectual development products.
For more information about iHuman, please visit
https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin
Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In China
Mr. Eric Yuan
Phone: +86-13801110739
E-mail: eric.yuan@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands of Renminbi (“RMB”)
and U.S. dollars (“US$”)
except
for number of shares, ADSs, per share and per ADS data)
| | |
December 31, | | |
June 30, | | |
June 30, | |
| | |
2022 | | |
2023 | | |
2023 | |
| | |
RMB | | |
RMB | | |
US$ | |
| ASSETS | |
| | | |
| | | |
| | |
| Current assets | |
| | | |
| | | |
| | |
| Cash and cash equivalents | |
| 1,049,999 | | |
| 967,472 | | |
| 133,420 | |
| Time deposits | |
| - | | |
| 137,290 | | |
| 18,933 | |
| Accounts receivable, net | |
| 79,614 | | |
| 58,982 | | |
| 8,134 | |
| Inventories, net | |
| 19,127 | | |
| 15,144 | | |
| 2,088 | |
| Amounts due from related parties | |
| 2,286 | | |
| 1,780 | | |
| 245 | |
| Prepayments and other current assets | |
| 102,765 | | |
| 92,630 | | |
| 12,774 | |
| Total current assets | |
| 1,253,791 | | |
| 1,273,298 | | |
| 175,594 | |
| Non-current assets | |
| | | |
| | | |
| | |
| Property and equipment, net | |
| 9,205 | | |
| 7,284 | | |
| 1,005 | |
| Intangible assets, net | |
| 24,872 | | |
| 24,707 | | |
| 3,407 | |
| Operating lease right-of-use assets | |
| 12,782 | | |
| 3,626 | | |
| 500 | |
| Long-term investment | |
| 26,333 | | |
| 26,333 | | |
| 3,631 | |
| Other non-current assets | |
| 6,416 | | |
| 6,659 | | |
| 922 | |
| Total non-current assets | |
| 79,608 | | |
| 68,609 | | |
| 9,465 | |
| Total assets | |
| 1,333,399 | | |
| 1,341,907 | | |
| 185,059 | |
| | |
| | | |
| | | |
| | |
| LIABILITIES | |
| | | |
| | | |
| | |
| Current liabilities | |
| | | |
| | | |
| | |
| Accounts payable | |
| 24,206 | | |
| 20,198 | | |
| 2,785 | |
| Deferred revenue and customer advances | |
| 379,063 | | |
| 325,828 | | |
| 44,934 | |
| Amounts due to related parties | |
| 6,944 | | |
| 3,529 | | |
| 487 | |
| Accrued expenses and other current liabilities | |
| 144,717 | | |
| 110,440 | | |
| 15,230 | |
| Current operating lease liabilities | |
| 6,123 | | |
| 1,566 | | |
| 216 | |
| Total current liabilities | |
| 561,053 | | |
| 461,561 | | |
| 63,652 | |
| Non-current liabilities | |
| | | |
| | | |
| | |
| Non-current operating lease liabilities | |
| 2,894 | | |
| 2,267 | | |
| 313 | |
| Total non-current liabilities | |
| 2,894 | | |
| 2,267 | | |
| 313 | |
| Total liabilities | |
| 563,947 | | |
| 463,828 | | |
| 63,965 | |
| SHAREHOLDERS’ EQUITY | |
| | | |
| | | |
| | |
| Ordinary shares (par value of US$0.0001 per share, 700,000,000 Class A shares authorized as of December 31, 2022 and June 30, 2023; 125,122,382 Class A shares issued and 121,722,467 outstanding as of December 31, 2022; 125,122,382 Class A shares issued and 119,857,402 outstanding as of June 30, 2023; 200,000,000 Class B shares authorized, 144,000,000 Class B ordinary shares issued and outstanding as of December 31, 2022 and June 30, 2023; 100,000,000 shares (undesignated) authorized, nil shares (undesignated) issued and outstanding as of December 31, 2022 and June 30, 2023) | |
| 185 | | |
| 185 | | |
| 26 | |
| Additional paid-in capital | |
| 1,079,099 | | |
| 1,083,937 | | |
| 149,482 | |
| Treasury stock | |
| (7,123 | ) | |
| (15,592 | ) | |
| (2,150 | ) |
| Statutory reserves | |
| 7,967 | | |
| 7,967 | | |
| 1,099 | |
| Accumulated other comprehensive income | |
| 10,497 | | |
| 27,035 | | |
| 3,728 | |
| Accumulated deficit | |
| (321,173 | ) | |
| (225,453 | ) | |
| (31,091 | ) |
| Total shareholders’ equity | |
| 769,452 | | |
| 878,079 | | |
| 121,094 | |
| Total liabilities and shareholders’ equity | |
| 1,333,399 | | |
| 1,341,907 | | |
| 185,059 | |
iHuman Inc.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS
(Amounts in thousands of Renminbi (“RMB”)
and U.S. dollars (“US$”)
except for number of shares, ADSs, per share
and per ADS data)
| | |
For
the three months ended | | |
For
the six months ended | |
| | |
June 30, | | |
March 31, | | |
June 30, | | |
June 30, | | |
June 30, | | |
June 30, | | |
June 30, | |
| | |
2022 | | |
2023 | | |
2023 | | |
2023 | | |
2022 | | |
2023 | | |
2023 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | | |
RMB | | |
RMB | | |
US$ | |
| Revenues | |
230,607 | | |
265,203 | | |
240,993 | | |
33,234 | | |
473,286 | | |
506,196 | | |
69,808 | |
| Cost of revenues | |
(67,417 | ) | |
(79,636 | ) | |
(70,160 | ) | |
(9,676 | ) | |
(140,214 | ) | |
(149,796 | ) | |
(20,658 | ) |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Gross
profit | |
163,190 | | |
185,567 | | |
170,833 | | |
23,558 | | |
333,072 | | |
356,400 | | |
49,150 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Operating expenses | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Research and development expenses | |
(78,201 | ) | |
(61,673 | ) | |
(63,412 | ) | |
(8,745 | ) | |
(174,826 | ) | |
(125,085 | ) | |
(17,250 | ) |
| Sales and marketing expenses | |
(33,530 | ) | |
(40,435 | ) | |
(40,564 | ) | |
(5,594 | ) | |
(69,436 | ) | |
(80,999 | ) | |
(11,170 | ) |
| General and
administrative expenses | |
(28,849 | ) | |
(26,735 | ) | |
(25,982 | ) | |
(3,583 | ) | |
(54,907 | ) | |
(52,717 | ) | |
(7,270 | ) |
| Total
operating expenses | |
(140,580 | ) | |
(128,843 | ) | |
(129,958 | ) | |
(17,922 | ) | |
(299,169 | ) | |
(258,801 | ) | |
(35,690 | ) |
| Operating
income | |
22,610 | | |
56,724 | | |
40,875 | | |
5,636 | | |
33,903 | | |
97,599 | | |
13,460 | |
| Other income,
net | |
2,917 | | |
6,082 | | |
8,132 | | |
1,121 | | |
6,264 | | |
14,214 | | |
1,960 | |
| Income before income taxes | |
25,527 | | |
62,806 | | |
49,007 | | |
6,757 | | |
40,167 | | |
111,813 | | |
15,420 | |
| Income tax
expenses | |
(3,737 | ) | |
(9,160 | ) | |
(6,933 | ) | |
(956 | ) | |
(5,259 | ) | |
(16,093 | ) | |
(2,219 | ) |
| Net
income | |
21,790 | | |
53,646 | | |
42,074 | | |
5,801 | | |
34,908 | | |
95,720 | | |
13,201 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Net income per ADS: | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| - Basic | |
0.41 | | |
1.01 | | |
0.80 | | |
0.11 | | |
0.66 | | |
1.81 | | |
0.25 | |
| - Diluted | |
0.40 | | |
0.98 | | |
0.77 | | |
0.11 | | |
0.64 | | |
1.75 | | |
0.24 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Weighted average number of ADSs: | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| - Basic | |
53,308,924 | | |
52,953,297 | | |
52,804,594 | | |
52,804,594 | | |
53,392,158 | | |
52,878,535 | | |
52,878,535 | |
| - Diluted | |
53,958,284 | | |
54,763,570 | | |
54,725,528 | | |
54,725,528 | | |
54,009,098 | | |
54,744,139 | | |
54,744,139 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Total share-based compensation
expenses included in: | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Cost of revenues | |
39 | | |
98 | | |
70 | | |
10 | | |
103 | | |
168 | | |
23 | |
| Research and development expenses | |
801 | | |
638 | | |
1,142 | | |
157 | | |
1,768 | | |
1,780 | | |
245 | |
| Sales and marketing expenses | |
430 | | |
379 | | |
59 | | |
8 | | |
342 | | |
438 | | |
60 | |
| General and administrative expenses | |
762 | | |
1,292 | | |
1,160 | | |
160 | | |
1,776 | | |
2,452 | | |
338 | |
iHuman Inc.
UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP
RESULTS
(Amounts in thousands of Renminbi (“RMB”)
and U.S. dollars (“US$”)
except for number of shares, ADSs, per share
and per ADS data)
| | |
For
the three months ended | | |
For
the six months ended | |
| | |
June 30, | | |
March 31, | | |
June 30, | | |
June 30, | | |
June 30, | | |
June 30, | | |
June 30, | |
| | |
2022 | | |
2023 | | |
2023 | | |
2023 | | |
2022 | | |
2023 | | |
2023 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | | |
RMB | | |
RMB | | |
US$ | |
| Operating income | |
22,610 | | |
56,724 | | |
40,875 | | |
5,636 | | |
33,903 | | |
97,599 | | |
13,460 | |
| Share-based
compensation expenses | |
2,032 | | |
2,407 | | |
2,431 | | |
335 | | |
3,989 | | |
4,838 | | |
666 | |
| Adjusted
operating income | |
24,642 | | |
59,131 | | |
43,306 | | |
5,971 | | |
37,892 | | |
102,437 | | |
14,126 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Net income | |
21,790 | | |
53,646 | | |
42,074 | | |
5,801 | | |
34,908 | | |
95,720 | | |
13,201 | |
| Share-based
compensation expenses | |
2,032 | | |
2,407 | | |
2,431 | | |
335 | | |
3,989 | | |
4,838 | | |
666 | |
| Adjusted
net income | |
23,822 | | |
56,053 | | |
44,505 | | |
6,136 | | |
38,897 | | |
100,558 | | |
13,867 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Diluted net income per ADS | |
0.40 | | |
0.98 | | |
0.77 | | |
0.11 | | |
0.64 | | |
1.75 | | |
0.24 | |
| Impact of
non-GAAP adjustments | |
0.04 | | |
0.04 | | |
0.04 | | |
0.00 | | |
0.08 | | |
0.09 | | |
0.01 | |
| Adjusted
diluted net income per ADS | |
0.44 | | |
1.02 | | |
0.81 | | |
0.11 | | |
0.72 | | |
1.84 | | |
0.25 | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Weighted average number of
ADSs – diluted | |
53,958,284 | | |
54,763,570 | | |
54,725,528 | | |
54,725,528 | | |
54,009,098 | | |
54,744,139 | | |
54,744,139 | |
| Weighted average number
of ADSs – adjusted | |
53,958,284 | | |
54,763,570 | | |
54,725,528 | | |
54,725,528 | | |
54,009,098 | | |
54,744,139 | | |
54,744,139 | |
Grafico Azioni iHuman (NYSE:IH)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni iHuman (NYSE:IH)
Storico
Da Nov 2023 a Nov 2024
